This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Medtronic, Inc., The United States Government as Represented by the Department of Veterans Affairs. Active years: 2016.
Company Filing History:
1 out of 8,944 
1 out of 955 
Years Active: 2016
Title: Innovations in Cardiac Substrate Identification by John F Beshai
Introduction
John F Beshai is an accomplished inventor based in Scottsdale, AZ (US). He has made significant contributions to the field of cardiac health, particularly in the identification of abnormal cardiac substrates. His innovative work has the potential to enhance the effectiveness of cardiac resynchronization therapy.
Latest Patents
John F Beshai holds a patent for the "Identification of abnormal cardiac substrate during left-ventricular pacing." This patent outlines techniques for identifying abnormal cardiac substrates, such as scar tissue, during the implantation of a left-ventricular lead. The system he developed includes an implantable LV lead with bipolar electrode pairs that sense the cardiac electrogram signal from the left ventricle. This technology allows for the delivery of cardiac pacing pulses while avoiding abnormal cardiac substrates, thereby improving patient outcomes.
Career Highlights
Throughout his career, John has worked with notable organizations, including Medtronic, Inc. and the United States Government as represented by the Department of Veterans Affairs. His experience in these institutions has contributed to his expertise in cardiac technologies and innovations.
Collaborations
John has collaborated with esteemed colleagues such as Nathan A Grenz and Brett D Atwater. Their combined efforts have further advanced the research and development of cardiac health technologies.
Conclusion
John F Beshai's innovative work in identifying abnormal cardiac substrates has the potential to significantly improve cardiac resynchronization therapy. His contributions to the field reflect a commitment to enhancing patient care through advanced technology.